共 50 条
- [43] A Time-Response Measure to Assess Clinical Equivalence in Rheumatoid Arthritis: An Assessment Using Data From Clinical Trials of Biosimilars STATISTICS IN BIOPHARMACEUTICAL RESEARCH, 2022, 14 (02): : 204 - 216
- [44] Quantitative measures for assessing rheumatoid arthritis in clinical trials and clinical care BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2003, 17 (05): : 753 - 781
- [45] PROVISIONAL GUIDELINES FOR MEASURING DISEASE-ACTIVITY IN CLINICAL-TRIALS ON RHEUMATOID-ARTHRITIS BRITISH JOURNAL OF RHEUMATOLOGY, 1992, 31 (12): : 793 - 794
- [46] Reporting Disease Activity in Clinical Trials of Patients With Rheumatoid Arthritis: EULAR/ACR Collaborative Recommendations ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2008, 59 (10): : 1371 - 1377
- [50] Eligibility of rheumatoid arthritis patients seen in clinical practice for rheumatoid arthritis clinical trials: comment on the article by Sokka and Pincus ARTHRITIS AND RHEUMATISM, 2003, 48 (12): : 3611 - 3611